Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05284084 · ClinicalTrials.gov registry record · NA
Prevention of Broncho-aspiration (BA) in Adult Subjects During Their ICU Stay
A NA study, sponsored by Marshall University.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
NCT05284084 is a NA study that has completed, run by Marshall University. The registered enrollment target is 159 participants.
The verdict
NCT05284084, a NA study, has completed, sponsored by Marshall University.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
Study Summary
Patients of age \>18 yo, admitted to the ICU through the surgery department from 2AUG2021 to 1AUG2022 will be divided into three groups: 1. Patients admitted to the ICU in the first 3-4 months will have their bed head elevated to 15 degrees + H2 blockers administration + mouth wash BID 2. Patients admitted to the ICU in the following 3-4 months will have their bed head elevated to 30 degrees + H2 blockers administration + mouth wash BID 3. Patients admitted in the last 3-4 months will have their bed head elevated to 45 degrees + H2 blockers administration + mouth wash BID. All patients will have their vital signs, BMI, and fluids ins and outs measured every 24 hours until the discharge from the ICU or death. All patients will be evaluated for GI functions (no vomiting, flatus+, bowel movement +, bowel sounds+, and KUB with normal gas distribution pattern) prior to oral intake. Patients in the three groups will be matched by age, sex, and BMI with historical controls with broncho- aspiration (BA) (positive controls) and without BA events (negative controls) from a pool of 20,032 ICU admissions (01JAN2010 to 31DEC2019).
Interventions
- OTHER Bed Head elevation, H2 blockers and mouth wash
- OTHER Data collection for comparison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2021-08-03 |
| Est. Completion | 2021-11-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05284084
The ClinicalTrials.gov registry entry for NCT05284084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marshall University, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bed Head elevation, H2 blockers and mouth wash is the first listed.
NCT05284084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05284084 about?
NCT05284084 is a clinical study titled "Prevention of Broncho-aspiration (BA) in Adult Subjects During Their ICU Stay". Patients of age \>18 yo, admitted to the ICU through the surgery department from 2AUG2021 to 1AUG2022 will be divided into three groups: 1. Patients admitted to the ICU in the first 3-4 months will have their bed head elevated to 15 degrees + H2 blockers administration + mouth wash BID 2. Patients ...
What is the current status of trial NCT05284084?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2021-08-03. Estimated completion is 2021-11-02.
What interventions are being tested in trial NCT05284084?
The interventions under investigation include: Bed Head elevation, H2 blockers and mouth wash (OTHER), Data collection for comparison (OTHER).
Who is sponsoring clinical trial NCT05284084?
This trial is sponsored by Marshall University, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.